EP3523353B1 - Dmpa-based solvent systems for the synthesis of poly(amic acid) and polyimide polymers - Google Patents
Dmpa-based solvent systems for the synthesis of poly(amic acid) and polyimide polymers Download PDFInfo
- Publication number
- EP3523353B1 EP3523353B1 EP16882805.1A EP16882805A EP3523353B1 EP 3523353 B1 EP3523353 B1 EP 3523353B1 EP 16882805 A EP16882805 A EP 16882805A EP 3523353 B1 EP3523353 B1 EP 3523353B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- ether acetate
- dmpa
- solvent system
- component
- glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002904 solvent Substances 0.000 title claims description 84
- 229920005575 poly(amic acid) Polymers 0.000 title claims description 64
- 229920000642 polymer Polymers 0.000 title claims description 40
- 229920001721 polyimide Polymers 0.000 title claims description 25
- 239000004642 Polyimide Substances 0.000 title claims description 23
- 230000015572 biosynthetic process Effects 0.000 title claims description 13
- 238000003786 synthesis reaction Methods 0.000 title claims description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 52
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 claims description 46
- -1 alkyl phosphate Chemical compound 0.000 claims description 45
- 229910019142 PO4 Inorganic materials 0.000 claims description 34
- DQWPFSLDHJDLRL-UHFFFAOYSA-N triethyl phosphate Chemical compound CCOP(=O)(OCC)OCC DQWPFSLDHJDLRL-UHFFFAOYSA-N 0.000 claims description 24
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 claims description 23
- 150000003462 sulfoxides Chemical class 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 22
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 19
- 239000010452 phosphate Substances 0.000 claims description 16
- VATRWWPJWVCZTA-UHFFFAOYSA-N 3-oxo-n-[2-(trifluoromethyl)phenyl]butanamide Chemical compound CC(=O)CC(=O)NC1=CC=CC=C1C(F)(F)F VATRWWPJWVCZTA-UHFFFAOYSA-N 0.000 claims description 15
- NQBXSWAWVZHKBZ-UHFFFAOYSA-N 2-butoxyethyl acetate Chemical compound CCCCOCCOC(C)=O NQBXSWAWVZHKBZ-UHFFFAOYSA-N 0.000 claims description 14
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 claims description 13
- MBHINSULENHCMF-UHFFFAOYSA-N n,n-dimethylpropanamide Chemical compound CCC(=O)N(C)C MBHINSULENHCMF-UHFFFAOYSA-N 0.000 claims description 13
- LAVARTIQQDZFNT-UHFFFAOYSA-N 1-(1-methoxypropan-2-yloxy)propan-2-yl acetate Chemical compound COCC(C)OCC(C)OC(C)=O LAVARTIQQDZFNT-UHFFFAOYSA-N 0.000 claims description 11
- UYAAVKFHBMJOJZ-UHFFFAOYSA-N diimidazo[1,3-b:1',3'-e]pyrazine-5,10-dione Chemical compound O=C1C2=CN=CN2C(=O)C2=CN=CN12 UYAAVKFHBMJOJZ-UHFFFAOYSA-N 0.000 claims description 11
- 229940116423 propylene glycol diacetate Drugs 0.000 claims description 11
- VXQBJTKSVGFQOL-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethyl acetate Chemical compound CCCCOCCOCCOC(C)=O VXQBJTKSVGFQOL-UHFFFAOYSA-N 0.000 claims description 10
- 150000004985 diamines Chemical class 0.000 claims description 9
- 239000000178 monomer Substances 0.000 claims description 9
- 125000004122 cyclic group Chemical group 0.000 claims description 5
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- 125000006158 tetracarboxylic acid group Chemical group 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 62
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 36
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 34
- 235000021317 phosphate Nutrition 0.000 description 25
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 21
- 229910052757 nitrogen Inorganic materials 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 16
- VLDPXPPHXDGHEW-UHFFFAOYSA-N 1-chloro-2-dichlorophosphoryloxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(Cl)=O VLDPXPPHXDGHEW-UHFFFAOYSA-N 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 13
- HLBLWEWZXPIGSM-UHFFFAOYSA-N 4-Aminophenyl ether Chemical compound C1=CC(N)=CC=C1OC1=CC=C(N)C=C1 HLBLWEWZXPIGSM-UHFFFAOYSA-N 0.000 description 12
- 239000008364 bulk solution Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 8
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 8
- 230000035484 reaction time Effects 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 6
- 239000000010 aprotic solvent Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 239000003586 protic polar solvent Substances 0.000 description 5
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 125000003277 amino group Chemical class 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 description 2
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 2
- WAEVWDZKMBQDEJ-UHFFFAOYSA-N 2-[2-(2-methoxypropoxy)propoxy]propan-1-ol Chemical compound COC(C)COC(C)COC(C)CO WAEVWDZKMBQDEJ-UHFFFAOYSA-N 0.000 description 2
- YBRVSVVVWCFQMG-UHFFFAOYSA-N 4,4'-diaminodiphenylmethane Chemical compound C1=CC(N)=CC=C1CC1=CC=C(N)C=C1 YBRVSVVVWCFQMG-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 238000011143 downstream manufacturing Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 150000003949 imides Chemical class 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003880 polar aprotic solvent Substances 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- GGAUUQHSCNMCAU-ZXZARUISSA-N (2s,3r)-butane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C[C@H](C(O)=O)[C@H](C(O)=O)CC(O)=O GGAUUQHSCNMCAU-ZXZARUISSA-N 0.000 description 1
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- LOWMYOWHQMKBTM-UHFFFAOYSA-N 1-butylsulfinylbutane Chemical compound CCCCS(=O)CCCC LOWMYOWHQMKBTM-UHFFFAOYSA-N 0.000 description 1
- VOZKAJLKRJDJLL-UHFFFAOYSA-N 2,4-diaminotoluene Chemical compound CC1=CC=C(N)C=C1N VOZKAJLKRJDJLL-UHFFFAOYSA-N 0.000 description 1
- WMDZKDKPYCNCDZ-UHFFFAOYSA-N 2-(2-butoxypropoxy)propan-1-ol Chemical compound CCCCOC(C)COC(C)CO WMDZKDKPYCNCDZ-UHFFFAOYSA-N 0.000 description 1
- CUDYYMUUJHLCGZ-UHFFFAOYSA-N 2-(2-methoxypropoxy)propan-1-ol Chemical compound COC(C)COC(C)CO CUDYYMUUJHLCGZ-UHFFFAOYSA-N 0.000 description 1
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 1
- JDSQBDGCMUXRBM-UHFFFAOYSA-N 2-[2-(2-butoxypropoxy)propoxy]propan-1-ol Chemical compound CCCCOC(C)COC(C)COC(C)CO JDSQBDGCMUXRBM-UHFFFAOYSA-N 0.000 description 1
- FYYLCPPEQLPTIQ-UHFFFAOYSA-N 2-[2-(2-propoxypropoxy)propoxy]propan-1-ol Chemical compound CCCOC(C)COC(C)COC(C)CO FYYLCPPEQLPTIQ-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 1
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 1
- LBPVOEHZEWAJKQ-UHFFFAOYSA-N 3-[4-(3-aminophenoxy)phenoxy]aniline Chemical compound NC1=CC=CC(OC=2C=CC(OC=3C=C(N)C=CC=3)=CC=2)=C1 LBPVOEHZEWAJKQ-UHFFFAOYSA-N 0.000 description 1
- BEKFRNOZJSYWKZ-UHFFFAOYSA-N 4-[2-(4-aminophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]aniline Chemical compound C1=CC(N)=CC=C1C(C(F)(F)F)(C(F)(F)F)C1=CC=C(N)C=C1 BEKFRNOZJSYWKZ-UHFFFAOYSA-N 0.000 description 1
- CQMIJLIXKMKFQW-UHFFFAOYSA-N 4-phenylbenzene-1,2,3,5-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C(C(=O)O)=CC(C(O)=O)=C1C1=CC=CC=C1 CQMIJLIXKMKFQW-UHFFFAOYSA-N 0.000 description 1
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 1
- QHHKLPCQTTWFSS-UHFFFAOYSA-N 5-[2-(1,3-dioxo-2-benzofuran-5-yl)-1,1,1,3,3,3-hexafluoropropan-2-yl]-2-benzofuran-1,3-dione Chemical compound C1=C2C(=O)OC(=O)C2=CC(C(C=2C=C3C(=O)OC(=O)C3=CC=2)(C(F)(F)F)C(F)(F)F)=C1 QHHKLPCQTTWFSS-UHFFFAOYSA-N 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- KKUKTXOBAWVSHC-UHFFFAOYSA-N Dimethylphosphate Chemical compound COP(O)(=O)OC KKUKTXOBAWVSHC-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 150000008064 anhydrides Chemical group 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- CURBACXRQKTCKZ-UHFFFAOYSA-N cyclobutane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C1C(C(O)=O)C(C(O)=O)C1C(O)=O CURBACXRQKTCKZ-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- UCQFCFPECQILOL-UHFFFAOYSA-N diethyl hydrogen phosphate Chemical compound CCOP(O)(=O)OCC UCQFCFPECQILOL-UHFFFAOYSA-N 0.000 description 1
- CCAFPWNGIUBUSD-UHFFFAOYSA-N diethyl sulfoxide Chemical compound CCS(=O)CC CCAFPWNGIUBUSD-UHFFFAOYSA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- QVKQJEWZVQFGIY-UHFFFAOYSA-N dipropyl hydrogen phosphate Chemical compound CCCOP(O)(=O)OCCC QVKQJEWZVQFGIY-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010292 electrical insulation Methods 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- ZJXZSIYSNXKHEA-UHFFFAOYSA-N ethyl dihydrogen phosphate Chemical compound CCOP(O)(O)=O ZJXZSIYSNXKHEA-UHFFFAOYSA-N 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- CAAULPUQFIIOTL-UHFFFAOYSA-N methyl dihydrogen phosphate Chemical compound COP(O)(O)=O CAAULPUQFIIOTL-UHFFFAOYSA-N 0.000 description 1
- GXMIHVHJTLPVKL-UHFFFAOYSA-N n,n,2-trimethylpropanamide Chemical compound CC(C)C(=O)N(C)C GXMIHVHJTLPVKL-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- MHZDONKZSXBOGL-UHFFFAOYSA-N propyl dihydrogen phosphate Chemical compound CCCOP(O)(O)=O MHZDONKZSXBOGL-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000004763 sulfides Chemical class 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- ISXOBTBCNRIIQO-UHFFFAOYSA-N tetrahydrothiophene 1-oxide Chemical compound O=S1CCCC1 ISXOBTBCNRIIQO-UHFFFAOYSA-N 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 1
- RXPQRKFMDQNODS-UHFFFAOYSA-N tripropyl phosphate Chemical compound CCCOP(=O)(OCCC)OCCC RXPQRKFMDQNODS-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1067—Wholly aromatic polyimides, i.e. having both tetracarboxylic and diamino moieties aromatically bound
- C08G73/1071—Wholly aromatic polyimides containing oxygen in the form of ether bonds in the main chain
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1003—Preparatory processes
- C08G73/1007—Preparatory processes from tetracarboxylic acids or derivatives and diamines
- C08G73/1028—Preparatory processes from tetracarboxylic acids or derivatives and diamines characterised by the process itself, e.g. steps, continuous
- C08G73/1032—Preparatory processes from tetracarboxylic acids or derivatives and diamines characterised by the process itself, e.g. steps, continuous characterised by the solvent(s) used
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1046—Polyimides containing oxygen in the form of ether bonds in the main chain
- C08G73/105—Polyimides containing oxygen in the form of ether bonds in the main chain with oxygen only in the diamino moiety
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1057—Polyimides containing other atoms than carbon, hydrogen, nitrogen or oxygen in the main chain
- C08G73/1064—Polyimides containing other atoms than carbon, hydrogen, nitrogen or oxygen in the main chain containing sulfur
Definitions
- This invention relates to an environmentally friendly, solvent system for the synthesis of poly(amic acid) (PAA) and polyimide (PI) polymers.
- PAA poly(amic acid)
- PI polyimide
- WO-A-2015/186782 relates to a method for producing a polyimide film, the method characterized by coating a substrate with a poly(amic acid) solution composition, which contains a poly(amic acid) and at least one type of solvent selected from among the group consisting of N-methylformamide, N,N-dimethylpropionamide, N, N-dimethylisobutylamide, and tetramethyl urea, and heat treating the composition so as to effect imidization and obtain a polyimide film.
- a poly(amic acid) solution composition which contains a poly(amic acid) and at least one type of solvent selected from among the group consisting of N-methylformamide, N,N-dimethylpropionamide, N, N-dimethylisobutylamide, and tetramethyl urea
- JP-A-2007256485 relates to a liquid crystal aligning agent that comprises a polyamic acid, an imidized polymer having a structure obtained by dehydration ring-closing of the polyamic acid, or a mixture of the polyamic acid and the imidized polymer.
- the polyamic acid is obtained by the reaction of a tetracarboxylic acid dianhydride with a diamine compound, wherein the tetracarboxylic acid dianhydride is a specified compound such as butane tetracarboxylic acid dianhydride and 1,2,3,4-cyclobutane tetracarboxylic acid dianhydride and the diamine compound is a specified compound such as p-phenylenediamine and 4,4'diaminodiphenylmethane.
- the tetracarboxylic acid dianhydride is a specified compound such as butane tetracarboxylic acid dianhydride and 1,2,3,4-cyclobutane tetracarboxylic acid dianhydride
- the diamine compound is a specified compound such as p-phenylenediamine and 4,4'diaminodiphenylmethane.
- US-A-2014/066590 relates to a polyimide precursor; having its terminal amino group modified with at least one alicyclic epoxydicarboxylic acid anhydride selected from the group consisting of a compound of formulae [1] and a compound of formula [2], or a polyimide thereof: wherein:
- Polyimide polymers are useful in a variety of applications, including the manufacture of electronic devices such as semiconductors and display units.
- PAA polymers are the processible, soluble precursor polymers of PI polymers.
- Tg glass transition
- Many PI polymers, and their PAA polymer precursors are synthesized in solvents now classified as harmful, such as N-methyl-2-pyrrolidone (NMP), N,N-dimethyl acetamide (DMAc), and N,N-dimethyl formamide (DMF).
- NMP N-methyl-2-pyrrolidone
- DMAc N,N-dimethyl acetamide
- DMF N,N-dimethyl formamide
- the invention is a process for synthesizing poly(amic acid) polymer, the process comprising the step of contacting under synthesis conditions and in a solvent system, (i) a cyclic tetracarboxylic dianhydride, e.g., pyromellitic dianhydride (PMDA), and (ii) a diamine monomer, e.g., 4,4'-diaminodiphenyl ether (ODA), wherein the solvent system consists essentially of:
- the invention is a process for synthesizing a polyimide polymer from a poly(amic acid) polymer in a solvent system, wherein the solvent system consists essentially of:
- the numerical ranges disclosed herein include all values from, and including, the lower and upper value.
- explicit values e.g., 1 to 7
- any subrange between any two explicit values is included (e.g., 1 to 2; 2 to 6; 5 to 7; 3 to 7; 5 to 6; etc.).
- compositions claimed through use of the term “comprising” may include any additional additive, adjuvant, or compound, whether polymeric or otherwise, unless stated to the contrary.
- the term, “consisting essentially of” excludes from the scope of any succeeding recitation any other component, step, or procedure, excepting those that are not essential to operability.
- the term “consisting of” excludes any component, step, or procedure not specifically delineated or listed.
- solvent and like terms mean a substance that is capable of dissolving another substance (i.e., a solute) to form an essentially uniformly dispersed mixture (i.e., solution) at the molecular or ionic size level.
- Diamine and like terms mean any compound containing two amine groups.
- Dianhydride and like terms mean any compound containing two anhydride groups.
- Aprotic and like terms describe a solvent, e.g., a glycol ether, that is not capable of donating a proton.
- Protic solvents are a solvents that have a hydrogen atom bound to an oxygen (as in a hydroxyl group) or a nitrogen (as in an amine group). In general terms, any solvent that contains labile H+ is a protic solvent.
- protic solvents include DOWANOL TM DPM (dipropylene glycol methyl ether), DOWANOL TM TPM (tripropylene glycol methyl ether), DOWANOL TM DPnP (dipropylene glycol n-propyl ether), DOWANOL TM DPnB (dipropylene glycol n-butyl ether), and DOWANOL TM TPnB (tripropylene glycol n-propyl ether).
- the molecules of such solvents readily donate protons (H+) to reagents.
- the glycol ethers used in the practice of this invention do not contain labile H+.
- aprotic solvents that can be used in the practice of this invention may contain minor amounts of residual protic compounds from the manufacturing process by which the aprotic solvent is made.
- Minimum amounts means typically less than or equal to ( ⁇ ) 1 wt%, or ⁇ 0.5 wt%, or ⁇ 0.1 wt%, or ⁇ 0.05 wt%, or ⁇ 0.01 wt%, of protic compound in the aprotic solvent based on the combined weight of the aprotic solvent and protic compound.
- Poly(amic acid) is an intermediate polymer in the synthesis of polyimide. It is soluble in polar solvents due to strong hydrogen bonding.
- Polyimide (PI) is a polymer made either from the polymerization of imide monomers or, as is the case in the present invention, from the ring closure of poly(amic acid). It is normally produced from the reaction of a cyclic tetracarboxylic dianhydride and a diamine that forms a poly(amic acid) that is subsequently ring closed by thermal and/or chemical means to form the imide moiety.
- KAPTON TM It is produced from the condensation of pyromellitic dianhydride and 4,4'-oxydiphenylamine and its subsequent ring closure.
- Synthesis conditions and like terms mean the pressure, and/or other conditions required to produce a product from reactants.
- typical synthesis conditions include ambient temperature and pressure, e.g., 20°C and atmospheric pressure, and an inert atmosphere, e.g., nitrogen.
- the solvents of this invention consist essentially of a first component and an optional second component.
- the first component consists essentially of, or consists of, DMPA.
- the second component consists essentially of, or consists of, at least one of a sulfoxide, an alkyl phosphate, and an aprotic glycol ether.
- the second component consists essentially of, or consists of, a sulfoxide.
- the second component consists essentially of, or consists of, an alkyl phosphate.
- the second component consists essentially of, or consists of, an aprotic glycol ether.
- the second component consists essentially of, or consists of, a sulfoxide and an alkyl phosphate.
- the second component consists essentially of, or consists of, a sulfoxide and an aprotic glycol ether.
- the second component consists essentially of, or consists of, an alkyl phosphate and an aprotic glycol ether.
- the second component consists essentially of, or consists of, an alkyl phosphate and an aprotic glycol ether.
- the second component consists essentially of, or consists of, two or more sulfoxides, or two or more alkyl phosphates, or two or more aprotic glycol ethers. In one embodiment the second component consists essentially of, or consists of, (i) two or more sulfoxides, and (ii) one or more alkyl phosphates, or one or more aprotic glycol ethers. In one embodiment the second component consists essentially of, or consists of, (i) two or more alkyl phosphates, and (ii) one or more sulfoxides, or one or more aprotic glycol ethers.
- the second component consists essentially of, or consists of, (i) two or more aprotic glycol ethers, and (ii) one or more sulfoxides or one or more alkyl phosphates. If the second component consists essentially of, or consists of, two or more materials, e.g., two or more sulfoxides, or two or more alkyl phosphates, or two or more aprotic glycol ethers, or at least two of a sulfoxide, an alkyl phosphate and aprotic glycol ether, then the second component is a blend that may or may not be phase separated.
- the solvent system consists of a first and second component
- the system is a blend that may or may not be phase separated.
- Homogeneous solvent systems i.e., solvent systems in which the individual components are miscible with one another (are not phase separated), are preferred.
- the first component consists of, or consists essentially of, DMPA ( CAS Number 758-96-3 ).
- the second component of the solvent of this invention consists essentially of, or consists of, a sulfoxide, i.e., a compound containing a sulfinyl functional group attached to two carbon atoms. It is a polar functional group.
- Sulfoxides are the oxidized derivatives of sulfides. Representative sulfoxides include, but are not limited to, diethyl sulfoxide, butyl sulfoxide, tetramethylene sulfoxide and dimethyl sulfoxide (DMSO).
- the second component of the solvent of this invention consists essentially of, or consists of, an alkyl phosphate, i.e., an organophosphate that is an ester of phosphoric acid and at least one corresponding alcohol.
- an alkyl phosphate i.e., an organophosphate that is an ester of phosphoric acid and at least one corresponding alcohol.
- monoalkyl phosphates RH 2 PO 4
- dialkyl phosphates R 2 HPO 4
- two of the three hydrogens of phosphoric acid are replaced by alkyl groups.
- trialkyl phosphates R 3 HPO 4
- all three hydrogens of phosphoric acid are replaced by alkyl groups.
- R is an alkyl group of 1 to 12 carbon atoms, typically of 1 to 10 carbon atoms, and more typically of 2 to 6 carbon atoms.
- the alkyl group can be straight, branched or cyclic with straight preferred.
- Representative alkyl phosphates include, but are not limited to, methyl phosphate (CH 3 H 2 PO 4 ), ethyl phosphate (CH 3 CH 2 H 2 PO 4 ), propyl phosphate (CH 3 CH 2 CH 2 H 2 PO 4 ), diethyl phosphate ((CH 3 CH 2 ) 2 HPO 4 ), dipropyl phosphate ((CH 3 CH 2 CH 2 ) 2 HPO 4 ), triethyl phosphate ((CH 3 CH 2 ) 3 PO 4 ), and tripropyl phosphate ((CH 3 CH 2 CH 2 ) 3 PO 4 ).
- Alkyl phosphates with actual or perceived environmental issues e.g., dimethyl phosphate ((CH 3 ) 2 HPO 4 ) and trimethyl phosphate ((CH 3 ) 3 PO 4 ), are disfavored for use in the practice of this invention.
- the second component of the solvent system consists essentially of, or consists of, an aprotic glycol ether, e.g., an acetylated or etherified compound based on an alkyl ether of ethylene glycol, propylene glycol or other alkyl, e.g., butyl, glycol.
- an aprotic glycol ether e.g., an acetylated or etherified compound based on an alkyl ether of ethylene glycol, propylene glycol or other alkyl, e.g., butyl, glycol.
- Representative aprotic glycol ethers include, but are not limited to, dipropylene glycol dimethyl ether, propylene glycol methyl ether acetate, propylene glycol diacetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol methyl ether acetate.
- protic solvents such as ethylene glycol monobutyl ether, ethylene glycol monopropyl ether, diethylene glycol monoethyl ether, propylene glycol methyl ether, dipropylene glycol monomethyl ether and tripropylene glycol monomethyl ether, are present in the solvent systems of this invention only as a residue of the manufacturing process from which the aprotic component of in the solvent system is made, and then in only minor amounts, e.g., less than or equal to ( ⁇ ) 1 wt%, based on the combined weight of the aprotic and protic compounds in the solvent system.
- the protic solvents are disfavored due to their tendency to react with the dianhydride reagent, e.g., monomer, of the process for making PAA, and tend to lead to PAA of lower molecular weight or lower inherent viscosity as compared to PAA made using an aprotic solvent.
- the dianhydride reagent e.g., monomer
- the second component can consist essentially of, or consist of, one or more aprotic glycol ethers. In one embodiment the second component consists of one aprotic glycol ether. In one embodiment the second component consists essentially of, or consists of, two or more aprotic glycol ethers. In one embodiment the second component is an aprotic ethylene glycol alkyl ether. In one embodiment the second component is an aprotic propylene glycol alkyl ether. In one embodiment the alkyl component of the aprotic ethylene or propylene glycol ether is an alkyl group of 1 to 12, or 2 to 10, or 3 to 8, carbon atoms.
- the second component consists of, or is, ethylene glycol n-butyl ether acetate ( CAS #112-07-02 ). In one embodiment the second component consists of, or is, propylene glycol methyl ether acetate ( CAS #108-65-6 ). In one embodiment the second component consists of, or is, dipropylene glycol dimethyl ether ( CAS Number 111109-77-4 ).
- aprotic glycol ethers that can be used in the practice of this invention include, but are not limited to, DOWANOL TM PMA (propylene glycol methyl ether acetate), DOWANOL TM DPMA (dipropylene glycol methyl ether acetate), DOWANOL TM PGDA (propylene glycol diacetate), Butyl CELLOSOLVE TM acetate (ethylene glycol n-butyl ether acetate), Butyl CARBITOL TM acetate (diethylene glycol n-butyl ether acetate), and PROGLYDE TM DMM (dipropylene glycol dimethyl ether), all available from The Dow Chemical Company.
- DOWANOL TM PMA propylene glycol methyl ether acetate
- DOWANOL TM DPMA dipropylene glycol methyl ether acetate
- DOWANOL TM PGDA propylene glycol diacetate
- the second component consists of, or is, DMSO ( CAS Number 67-68-5 ). In one embodiment the second component consists of, or is, triethyl phosphate ( CAS Number 78-40-0 ). In one embodiment the second component consists of, or is, ethylene glycol butyl ether acetate. In one embodiment the second component consists of, or is, propylene glycol methyl ether acetate. In one embodiment the second component consists of, or is, dipropylene glycol dimethyl ether ( CAS Number 111109-77-4 ).
- the second component consists essentially of, or consists of, (i) DMSO, and (ii) triethyl phosphate, or at least one of ethylene glycol n-butyl ether acetate, propylene glycol methyl ether acetate, and dipropylene glycol dimethyl ether.
- the second component consists essentially of, or consists of, (i) triethyl phosphate, and (ii) DMSO, or at least one of ethylene glycol n-butyl ether acetate, propylene glycol methyl ether acetate and dipropylene glycol dimethyl ether.
- the second component consists essentially of, or consists of, (i) at least one of ethylene glycol n-butyl ether acetate, propylene glycol methyl ether and dipropylene glycol dimethyl ether, and (ii) at least one of DMSO and triethyl phosphate.
- the solvent system consists of DMPA and a sulfoxide.
- the solvent system consists of DMPA and an alkyl phosphate.
- the solvent system consists of DMPA and a trialkyl phosphate.
- the solvent system consists of DMPA and an aprotic glycol ether.
- the solvent system consists of DMPA, a sulfoxide and an alkyl phosphate.
- the solvent system consists of DMPA, a sulfoxide and a glycol ether.
- the solvent system consists of DMPA, an alkyl phosphate and an aprotic glycol ether.
- the solvent system consists of DMPA, a sulfoxide, an alkyl phosphate and an aprotic glycol ether.
- the solvent system consists of DMPA and DMSO.
- the solvent system consists of DMPA and triethyl phosphate.
- the solvent system consists of DMPA and at least one of propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol diacetate, ethylene glycol n-butyl ether acetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol dimethyl ether.
- the solvent system consists of DMPA, DMSO and triethyl phosphate.
- the solvent system consists of DMPA, DMSO and at least one of propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol diacetate, ethylene glycol n-butyl ether acetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol dimethyl ether.
- the solvent system consists of DMPA, triethyl phosphate, and at least one of propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol diacetate, ethylene glycol n-butyl ether acetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol dimethyl ether.
- the solvent system consists of DMPA, DMSO, triethyl phosphate, and at least one of propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol diacetate, ethylene glycol n-butyl ether acetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol dimethyl ether.
- the solvent system consists of, or consists essentially of, in weight percent (wt%) based on the weight of the solvent system, from 10 to 100 wt%, or from 20 to 80 wt%, or from 30 to 70 wt %, or from 40 to 60 wt% of the first component, and from 0 to 90 wt%, or from 20 to 80 wt%, or from 30 to 70 wt% or from 40 to 60 wt% of the second component.
- wt% weight percent
- the solvent system consists of, or consists essentially of, in weight percent (wt%) based on the weight of the solvent system, from 10 to 100 wt%, or from 20 to 80 wt%, or from 40 to 60 wt%, of DMPA, and from 0 to 90 wt%, or from 20 to 80 wt%, or from 40 to 60 wt%, of one or more of a sulfoxide and an alkyl phosphate.
- wt% weight percent
- the solvent system consists of, or consists essentially of, in weight percent (wt%) based on the weight of the solvent system, from 30 to 100 wt%, or from 40 to 90 wt%, or from 45 to 65 wt%, of DMPA, and from 0 to 70 wt%, or from 10 to 60 wt%, or from 35 to 55 wt%, of a glycol ether.
- the solvent system consists of, or consists essentially of, in weight percent (wt%) based on the weight of the solvent system, from 30 to 100 wt%, or from 40 to 90 wt%, or from 45 to 65 wt%, of DMPA, and from 0 to 70 wt%, or from 10 to 60 wt%, or from 35 to 55 wt%, of at least one of propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol diacetate, ethylene glycol n-butyl ether acetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol dimethyl ether.
- wt% weight percent
- the solvent system consists of, or consists essentially of, in weight percent (wt%) based on the weight of the solvent system, from 10 to 100 wt%, or from 20 to 80 wt%, or from 40 to 60 wt%, of DMPA, and from 0 to 90 wt%, or from 20 to 80 wt%, or from 40 to 60 wt%, of DMSO.
- the solvent system consists of, or consists essentially of, in weight percent (wt%) based on the weight of the solvent system, from 10 to 100 wt%, or from 20 to 80 wt%, or from 40 to 60 wt%, of DMPA, and from 0 to 90 wt%, or from 20 to 80 wt%, or from 40 to 60 wt%, of triethyl phosphate.
- the amount of each substance in a particular component can vary widely and to convenience.
- the amount of each individual substance in the component can vary from 0 to 100 wt%, or from 1 to 99 wt%, or from 10 to 90 wt%, or from 20 to 80 wt% or from 30 to 70 wt%, or from 40 to 60 wt%, or 50 wt%, based on the weight of the component.
- Optional materials that are not essential to the operability of, but can be included in, the solvent systems of this invention include, but are not limited to, antioxidants, colorants, water scavengers, stabilizers, fillers, diluents (e.g., aromatic hydrocarbons), and the like. These materials do not have any material impact on the efficacy of the solvent system for providing a reaction medium for the synthesis of PI and/or PAA. These optional materials are used in known amounts, e.g., 0.10 to 5, or 4, or 3, or 2, or 1, weight percent based on the weight of the solvent system, and they are used in known ways.
- Solvent systems of this invention consisting of, or consisting essentially of, two or more compounds, e.g., DMPA and DMSO and/or triethyl phosphate and/or an aprotic glycol ether, are made using known equipment and known techniques.
- the individual components of the solvent system are commercially available, liquid at ambient conditions (23°C and atmospheric pressure), and can simply be mixed with one another using conventional mixing equipment and standard blending protocols. The components can be added to one another in any order including simultaneously.
- the solvent systems of this invention are eco-solvents, i.e., they do not have, or have at a reduced level, the toxicology issues associated with NMP. These solvent systems are used in the same manner as mediums for the synthesis of PAA and PI as NMP or other polar aprotic solvent.
- reaction scheme is a nonlimiting, representative illustration of a PAA synthesis in which the solvent systems of this invention can be used.
- This scheme shows a simple reaction mechanism for producing a pyromellitic dianhydride (PMDA)/4,4'-diaminodiphenyl ether (ODA)-based PAA polymer with the exemplary repeating unit.
- PMDA pyromellitic dianhydride
- ODA diaminodiphenyl ether
- cyclic tetracarboxylic dianhydrides beyond pyromellitic dianhydride, that can be used in the practice of this invention include, but are not limited to, those described by formula I in which R is an unsubstituted or substituted aliphatic or aromatic group.
- Representative cyclic tetracarboxylic dianhydrides of formula I include, but are not limited to, 3,3'4,4'-biphenyltetracarboxylic dianhydride, 4,4'-(hexafluoroisopropylidene)-diphthalic anhydride, 3,3'4,4'-benzophenone-tetracarboxylic dianhydride, 1,2,3,4-cyclobutanetetra-carboxylic dianhydride, 3,3'4,4'-diphenyl-sulfonetetracarboxylic dianhydride, oxydiphthalic dianhydride, etc., such as those identified in USP 9,346,927 .
- R' is an unsubstituted or substituted aromatic group.
- Representative diamines include, but are not limited to, 3,4'-diaminophenylether, 1,3-phenylenediamine, 1,4-phenylenediamine, 4,4'-diaminodiphenylsulfone, 2,4-diamino-toluene, 4,4'-diaminodiphenylmethane, 2,2-bis(4-aminophenyl)-1,1,1,3,3,3-hexafluoropropane, 1,4-bis(3-amino-phenoxy)benzene, 3,3'-dimethylbenzidine, etc., such as those identified in USP 9,346,927 .
- Formula III is representative of a repeating unit of the various polymers that can be produced from the reaction of a cyclic tetracarboxylic dianhydride of formula I and a diamine of formula II using a solvent system of this invention.
- the PAA polymer is thermally converted, e.g., heated, into the PI polymer.
- the PAA is chemically converted, e.g., the PAA polymer is reacted with a ring-closing/dehydrating imidization agent such as acetic anhydride with a base catalyst, into the PI polymer.
- the PAA polymer is converted into the PI polymer using a combination of thermal and chemical techniques, e.g., reacting the PAA polymer with an imidization reagent at an elevated temperature. Imidization reagents and synthesis conditions for PI polymers are well known in the art, and are described in, among other publications, USP 3,410,826 , 5,789,524 and 5,919,892 .
- ⁇ inh in the examples, an aliquot of polyamic acid solution is weighed into a volumetric flask and diluted with 1-methyl-2-pyrrolidinone at 20°C to provide the polymer solution for measurement at a concentration of 0.10 g/dL.
- Inherent viscosity as a dilute solution viscosity measurement indicates the molecular weight of the polyamic acid prepared with a larger ⁇ inh value indicating higher molecular weight.
- a good alternative polymerization solvent system to NMP should result in ⁇ inh comparable (not less than 90%) or greater than a control polymerization in NMP.
- polyamic acid solution of equivalent weight percent solids and equivalent molecular weight in an alternative solvent to NMP have a bulk viscosity of no more than 3X of that measured in NMP, more preferably no more than 2X of that measured in NMP, even more preferably comparable or less than that measured in NMP.
- N,N-dimethylpropionamide 45 mL
- toluene 10 mL
- Toluene (10 mL) is distilled into Dean-Stark type trap and drained with Dean-Stark trap and condenser removed and flask placed under positive nitrogen.
- 4,4'-Diaminodiphenyl ether 2.964 g, 14.80 mmol
- N,N-dimethylpropionamide 25 mL
- toluene 5 mL
- Toluene (5 mL) is distilled into Dean-Stark type trap and drained with Dean-Stark trap and condenser removed and flask placed under positive nitrogen.
- Anhydrous dimethyl sulfoxide 25 mL
- 4,4'-Diaminodiphenyl ether (3.616 g, 18.06 mmol) is added to the room temperature flask and dissolves at room temperature.
- inventive solvents of the Table illustrate that under the same reaction conditions of time, temperature, monomer ratio stoichiometries, and solids loadings as the NMP control polymerizations, that the inventive solvents result in equivalent or higher molecular weight (MW) and in some cases, in spite of the higher molecular weight, have a lower bulk solution viscosity value.
- DMPA shows the comparable or higher molecular weight of the synthesized PAA compared to NMP.
- the bulk viscosity of the PAA solution is much lower than NMP without adding any additives to control the bulk viscosity of the PAA solution. Lowering both the bulk viscosity and the surface tension provide an advantage for the downstream coating or filming process.
- Blends of DMPA with other polar aprotic solvents like TEP and DMSO show comparable or higher molecular weight of the synthesized PAA compared to NMP.
- the bulk viscosity of the blends are lower or comparable which will facilitate the downstream processing (as well as lower cost) providing flexibility in having lower bulk viscosities at equivalent molecular weight or allow higher polymer solution loadings than the comparative examples
- Blends of DMPA with aprotic solvents like DOWANOL TM PMA and Butyl CELLOSOLVE TM acetate also show the comparable or higher MW of the synthesized PAA compared to NMP.
- the bulk viscosity of the PAA solution is higher than the PAA prepared with NMP.
- the bulk viscosity can be controlled via molecular weight control during the reaction and/or adding viscosity thinner as additive to lower the bulk viscosity of the PAA solution.
- mixed/blend solvent systems can provide advantages on the downstream processing such as easier casting/spin coating, easier evaporation, better color, better/faster processing to make coatings/films due to the attributes of the aprotic glycol ethers that relate to their properties/attributes whether it be viscosity, solubility parameters, volatility/evaporation rate, etc.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
Description
- This invention relates to an environmentally friendly, solvent system for the synthesis of poly(amic acid) (PAA) and polyimide (PI) polymers.
-
WO-A-2015/186782 relates to a method for producing a polyimide film, the method characterized by coating a substrate with a poly(amic acid) solution composition, which contains a poly(amic acid) and at least one type of solvent selected from among the group consisting of N-methylformamide, N,N-dimethylpropionamide, N, N-dimethylisobutylamide, and tetramethyl urea, and heat treating the composition so as to effect imidization and obtain a polyimide film. -
JP-A-2007256485 -
US-A-2014/066590 relates to a polyimide precursor; having its terminal amino group modified with at least one alicyclic epoxydicarboxylic acid anhydride selected from the group consisting of a compound of formulae [1] and a compound of formula [2], or a polyimide thereof: - Y is a C1-2 alkylene or an oxygen atom;
- R1 is a hydrogen atom or an organice group represented by -X 1-X 2-X 3;
- X1 is a single bond or -CH2-;
- X2 is a single bond or -O-; and
- X3 is a C1-20 alkyl group, a C1-20 haloalkyl group or a C1-20 alkyl group containing a cyano group.
- Polyimide polymers are useful in a variety of applications, including the manufacture of electronic devices such as semiconductors and display units. PAA polymers are the processible, soluble precursor polymers of PI polymers. Among the many properties of PI polymers that make them favorable for these applications are a high glass transition (Tg) temperature, high thermal stability, high oxidative and hydrolytic stability, good electrical insulation/dielectric properties, strong mechanical attributes, a low coefficient of thermal expansion, and the like. Many PI polymers, and their PAA polymer precursors, are synthesized in solvents now classified as harmful, such as N-methyl-2-pyrrolidone (NMP), N,N-dimethyl acetamide (DMAc), and N,N-dimethyl formamide (DMF).
- Much interest exists in finding alternative solvents to replace NMP and like materials in the synthesis of PI and PAA polymers. Such systems, however, need to exhibit not only a better environmental profile, but also comparable cost and performance.
- In one embodiment the invention is a process for synthesizing poly(amic acid) polymer, the process comprising the step of contacting under synthesis conditions and in a solvent system, (i) a cyclic tetracarboxylic dianhydride, e.g., pyromellitic dianhydride (PMDA), and (ii) a diamine monomer, e.g., 4,4'-diaminodiphenyl ether (ODA), wherein the solvent system consists essentially of:
- (A) a first component consisting essentially of N,N-dimethyl propionamide (DMPA), and
- (B) a second component consisting essentially of at least one of a sulfoxide, an alkyl phosphate, and an aprotic glycol ether.
- In one embodiment the invention is a process for synthesizing a polyimide polymer from a poly(amic acid) polymer in a solvent system, wherein the solvent system consists essentially of:
- (A) a first component consisting of N,N-dimethyl propionamide (DMPA), and
- (B) a second component consisting essentially of at least one of a sulfoxide, an alkyl phosphate, and an aprotic glycol ether.
- The numerical ranges disclosed herein include all values from, and including, the lower and upper value. For ranges containing explicit values (e.g., 1 to 7), any subrange between any two explicit values is included (e.g., 1 to 2; 2 to 6; 5 to 7; 3 to 7; 5 to 6; etc.).
- The terms "comprising," "including," "having," and their derivatives, are not intended to exclude the presence of any additional component, step or procedure, whether or not the same is specifically disclosed. In order to avoid any doubt, all compositions claimed through use of the term "comprising" may include any additional additive, adjuvant, or compound, whether polymeric or otherwise, unless stated to the contrary. In contrast, the term, "consisting essentially of" excludes from the scope of any succeeding recitation any other component, step, or procedure, excepting those that are not essential to operability. The term "consisting of" excludes any component, step, or procedure not specifically delineated or listed. The term "or," unless stated otherwise, refers to the listed members individually as well as in any combination. Use of the singular includes use of the plural and vice versa.
- Unless stated to the contrary, implicit from the context, or customary in the art, all parts and percents are based on weight and all test methods are current as of the filing date of this disclosure.
- "Solvent" and like terms mean a substance that is capable of dissolving another substance (i.e., a solute) to form an essentially uniformly dispersed mixture (i.e., solution) at the molecular or ionic size level.
- "Diamine" and like terms mean any compound containing two amine groups.
- "Dianhydride" and like terms mean any compound containing two anhydride groups.
- "Monomer" and like terms mean a compound that can undergo polymerization.
- "Aprotic" and like terms describe a solvent, e.g., a glycol ether, that is not capable of donating a proton. Protic solvents are a solvents that have a hydrogen atom bound to an oxygen (as in a hydroxyl group) or a nitrogen (as in an amine group). In general terms, any solvent that contains labile H+ is a protic solvent. Representative protic solvents include DOWANOL™ DPM (dipropylene glycol methyl ether), DOWANOL™ TPM (tripropylene glycol methyl ether), DOWANOL™ DPnP (dipropylene glycol n-propyl ether), DOWANOL™ DPnB (dipropylene glycol n-butyl ether), and DOWANOL™ TPnB (tripropylene glycol n-propyl ether). The molecules of such solvents readily donate protons (H+) to reagents. The glycol ethers used in the practice of this invention do not contain labile H+. The commercially available aprotic solvents that can be used in the practice of this invention may contain minor amounts of residual protic compounds from the manufacturing process by which the aprotic solvent is made. "Minor amounts" means typically less than or equal to (≤) 1 wt%, or ≤ 0.5 wt%, or ≤ 0.1 wt%, or ≤ 0.05 wt%, or ≤ 0.01 wt%, of protic compound in the aprotic solvent based on the combined weight of the aprotic solvent and protic compound.
- Poly(amic acid) is an intermediate polymer in the synthesis of polyimide. It is soluble in polar solvents due to strong hydrogen bonding.
- Polyimide (PI) is a polymer made either from the polymerization of imide monomers or, as is the case in the present invention, from the ring closure of poly(amic acid). It is normally produced from the reaction of a cyclic tetracarboxylic dianhydride and a diamine that forms a poly(amic acid) that is subsequently ring closed by thermal and/or chemical means to form the imide moiety. One common PI used in the electronics industry is KAPTON™ It is produced from the condensation of pyromellitic dianhydride and 4,4'-oxydiphenylamine and its subsequent ring closure.
- "Synthesis conditions" and like terms mean the pressure, and/or other conditions required to produce a product from reactants. In the context of producing a poly(amic acid) polymer from a dianhydride and a diamine, typical synthesis conditions include ambient temperature and pressure, e.g., 20°C and atmospheric pressure, and an inert atmosphere, e.g., nitrogen.
- The solvents of this invention consist essentially of a first component and an optional second component. The first component consists essentially of, or consists of, DMPA.
- The second component consists essentially of, or consists of, at least one of a sulfoxide, an alkyl phosphate, and an aprotic glycol ether. In one embodiment the second component consists essentially of, or consists of, a sulfoxide. In one embodiment the second component consists essentially of, or consists of, an alkyl phosphate. In one embodiment the second component consists essentially of, or consists of, an aprotic glycol ether. In one embodiment the second component consists essentially of, or consists of, a sulfoxide and an alkyl phosphate. In one embodiment the second component consists essentially of, or consists of, a sulfoxide and an aprotic glycol ether. In one embodiment the second component consists essentially of, or consists of, an alkyl phosphate and an aprotic glycol ether.
- In one embodiment the second component consists essentially of, or consists of, two or more sulfoxides, or two or more alkyl phosphates, or two or more aprotic glycol ethers. In one embodiment the second component consists essentially of, or consists of, (i) two or more sulfoxides, and (ii) one or more alkyl phosphates, or one or more aprotic glycol ethers. In one embodiment the second component consists essentially of, or consists of, (i) two or more alkyl phosphates, and (ii) one or more sulfoxides, or one or more aprotic glycol ethers. In one embodiment the second component consists essentially of, or consists of, (i) two or more aprotic glycol ethers, and (ii) one or more sulfoxides or one or more alkyl phosphates. If the second component consists essentially of, or consists of, two or more materials, e.g., two or more sulfoxides, or two or more alkyl phosphates, or two or more aprotic glycol ethers, or at least two of a sulfoxide, an alkyl phosphate and aprotic glycol ether, then the second component is a blend that may or may not be phase separated.
- If the solvent system consists of a first and second component, then the system is a blend that may or may not be phase separated. Homogeneous solvent systems, i.e., solvent systems in which the individual components are miscible with one another (are not phase separated), are preferred.
- The first component consists of, or consists essentially of, DMPA (CAS Number 758-96-3).
- In one embodiment the second component of the solvent of this invention consists essentially of, or consists of, a sulfoxide, i.e., a compound containing a sulfinyl functional group attached to two carbon atoms. It is a polar functional group. Sulfoxides are the oxidized derivatives of sulfides. Representative sulfoxides include, but are not limited to, diethyl sulfoxide, butyl sulfoxide, tetramethylene sulfoxide and dimethyl sulfoxide (DMSO).
- In one embodiment the second component of the solvent of this invention consists essentially of, or consists of, an alkyl phosphate, i.e., an organophosphate that is an ester of phosphoric acid and at least one corresponding alcohol. In monoalkyl phosphates (RH2PO4), only one of the three hydrogens of phosphoric acid are replaced by an alkyl group. In dialkyl phosphates (R2HPO4), two of the three hydrogens of phosphoric acid are replaced by alkyl groups. In trialkyl phosphates (R3HPO4), all three hydrogens of phosphoric acid are replaced by alkyl groups. R is an alkyl group of 1 to 12 carbon atoms, typically of 1 to 10 carbon atoms, and more typically of 2 to 6 carbon atoms. The alkyl group can be straight, branched or cyclic with straight preferred. Representative alkyl phosphates include, but are not limited to, methyl phosphate (CH3H2PO4), ethyl phosphate (CH3CH2H2PO4), propyl phosphate (CH3CH2CH2H2PO4), diethyl phosphate ((CH3CH2)2HPO4), dipropyl phosphate ((CH3CH2CH2)2HPO4), triethyl phosphate ((CH3CH2)3PO4), and tripropyl phosphate ((CH3CH2CH2)3PO4). Alkyl phosphates with actual or perceived environmental issues, e.g., dimethyl phosphate ((CH3)2HPO4) and trimethyl phosphate ((CH3)3PO4), are disfavored for use in the practice of this invention.
- In one embodiment of this invention, the second component of the solvent system consists essentially of, or consists of, an aprotic glycol ether, e.g., an acetylated or etherified compound based on an alkyl ether of ethylene glycol, propylene glycol or other alkyl, e.g., butyl, glycol. These compounds typically have a higher boiling point, together with the favorable solvent properties of lower-molecular weight ethers and alcohols. Representative aprotic glycol ethers include, but are not limited to, dipropylene glycol dimethyl ether, propylene glycol methyl ether acetate, propylene glycol diacetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol methyl ether acetate. In contrast, protic solvents such as ethylene glycol monobutyl ether, ethylene glycol monopropyl ether, diethylene glycol monoethyl ether, propylene glycol methyl ether, dipropylene glycol monomethyl ether and tripropylene glycol monomethyl ether, are present in the solvent systems of this invention only as a residue of the manufacturing process from which the aprotic component of in the solvent system is made, and then in only minor amounts, e.g., less than or equal to (≤) 1 wt%, based on the combined weight of the aprotic and protic compounds in the solvent system. The protic solvents are disfavored due to their tendency to react with the dianhydride reagent, e.g., monomer, of the process for making PAA, and tend to lead to PAA of lower molecular weight or lower inherent viscosity as compared to PAA made using an aprotic solvent.
- The second component can consist essentially of, or consist of, one or more aprotic glycol ethers. In one embodiment the second component consists of one aprotic glycol ether. In one embodiment the second component consists essentially of, or consists of, two or more aprotic glycol ethers. In one embodiment the second component is an aprotic ethylene glycol alkyl ether. In one embodiment the second component is an aprotic propylene glycol alkyl ether. In one embodiment the alkyl component of the aprotic ethylene or propylene glycol ether is an alkyl group of 1 to 12, or 2 to 10, or 3 to 8, carbon atoms. In one embodiment the second component consists of, or is, ethylene glycol n-butyl ether acetate (CAS #112-07-02). In one embodiment the second component consists of, or is, propylene glycol methyl ether acetate (CAS #108-65-6). In one embodiment the second component consists of, or is, dipropylene glycol dimethyl ether (CAS Number 111109-77-4). Commercially available aprotic glycol ethers that can be used in the practice of this invention include, but are not limited to, DOWANOL™ PMA (propylene glycol methyl ether acetate), DOWANOL™ DPMA (dipropylene glycol methyl ether acetate), DOWANOL™ PGDA (propylene glycol diacetate), Butyl CELLOSOLVE™ acetate (ethylene glycol n-butyl ether acetate), Butyl CARBITOL™ acetate (diethylene glycol n-butyl ether acetate), and PROGLYDE™ DMM (dipropylene glycol dimethyl ether), all available from The Dow Chemical Company.
- In one embodiment the second component consists of, or is, DMSO (CAS Number 67-68-5). In one embodiment the second component consists of, or is, triethyl phosphate (CAS Number 78-40-0). In one embodiment the second component consists of, or is, ethylene glycol butyl ether acetate. In one embodiment the second component consists of, or is, propylene glycol methyl ether acetate. In one embodiment the second component consists of, or is, dipropylene glycol dimethyl ether (CAS Number 111109-77-4). In one embodiment the second component consists essentially of, or consists of, (i) DMSO, and (ii) triethyl phosphate, or at least one of ethylene glycol n-butyl ether acetate, propylene glycol methyl ether acetate, and dipropylene glycol dimethyl ether. In one embodiment the second component consists essentially of, or consists of, (i) triethyl phosphate, and (ii) DMSO, or at least one of ethylene glycol n-butyl ether acetate, propylene glycol methyl ether acetate and dipropylene glycol dimethyl ether. In one embodiment the second component consists essentially of, or consists of, (i) at least one of ethylene glycol n-butyl ether acetate, propylene glycol methyl ether and dipropylene glycol dimethyl ether, and (ii) at least one of DMSO and triethyl phosphate.
- In one embodiment the solvent system consists of DMPA and a sulfoxide.
- In one embodiment the solvent system consists of DMPA and an alkyl phosphate.
- In one embodiment the solvent system consists of DMPA and a trialkyl phosphate.
- In one embodiment the solvent system consists of DMPA and an aprotic glycol ether.
- In one embodiment the solvent system consists of DMPA, a sulfoxide and an alkyl phosphate.
- In one embodiment the solvent system consists of DMPA, a sulfoxide and a glycol ether.
- In one embodiment the solvent system consists of DMPA, an alkyl phosphate and an aprotic glycol ether.
- In one embodiment the solvent system consists of DMPA, a sulfoxide, an alkyl phosphate and an aprotic glycol ether.
- In one embodiment the solvent system consists of DMPA and DMSO.
- In one embodiment the solvent system consists of DMPA and triethyl phosphate.
- In one embodiment the solvent system consists of DMPA and at least one of propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol diacetate, ethylene glycol n-butyl ether acetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol dimethyl ether.
- In one embodiment the solvent system consists of DMPA, DMSO and triethyl phosphate.
- In one embodiment the solvent system consists of DMPA, DMSO and at least one of propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol diacetate, ethylene glycol n-butyl ether acetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol dimethyl ether.
- In one embodiment the solvent system consists of DMPA, triethyl phosphate, and at least one of propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol diacetate, ethylene glycol n-butyl ether acetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol dimethyl ether.
- In one embodiment the solvent system consists of DMPA, DMSO, triethyl phosphate, and at least one of propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol diacetate, ethylene glycol n-butyl ether acetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol dimethyl ether.
- In one embodiment the solvent system consists of, or consists essentially of, in weight percent (wt%) based on the weight of the solvent system, from 10 to 100 wt%, or from 20 to 80 wt%, or from 30 to 70 wt %, or from 40 to 60 wt% of the first component, and from 0 to 90 wt%, or from 20 to 80 wt%, or from 30 to 70 wt% or from 40 to 60 wt% of the second component.
- In one embodiment the solvent system consists of, or consists essentially of, in weight percent (wt%) based on the weight of the solvent system, from 10 to 100 wt%, or from 20 to 80 wt%, or from 40 to 60 wt%, of DMPA, and from 0 to 90 wt%, or from 20 to 80 wt%, or from 40 to 60 wt%, of one or more of a sulfoxide and an alkyl phosphate.
- In one embodiment the solvent system consists of, or consists essentially of, in weight percent (wt%) based on the weight of the solvent system, from 30 to 100 wt%, or from 40 to 90 wt%, or from 45 to 65 wt%, of DMPA, and from 0 to 70 wt%, or from 10 to 60 wt%, or from 35 to 55 wt%, of a glycol ether.
- In one embodiment the solvent system consists of, or consists essentially of, in weight percent (wt%) based on the weight of the solvent system, from 30 to 100 wt%, or from 40 to 90 wt%, or from 45 to 65 wt%, of DMPA, and from 0 to 70 wt%, or from 10 to 60 wt%, or from 35 to 55 wt%, of at least one of propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol diacetate, ethylene glycol n-butyl ether acetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol dimethyl ether.
- In one embodiment the solvent system consists of, or consists essentially of, in weight percent (wt%) based on the weight of the solvent system, from 10 to 100 wt%, or from 20 to 80 wt%, or from 40 to 60 wt%, of DMPA, and from 0 to 90 wt%, or from 20 to 80 wt%, or from 40 to 60 wt%, of DMSO.
- In one embodiment the solvent system consists of, or consists essentially of, in weight percent (wt%) based on the weight of the solvent system, from 10 to 100 wt%, or from 20 to 80 wt%, or from 40 to 60 wt%, of DMPA, and from 0 to 90 wt%, or from 20 to 80 wt%, or from 40 to 60 wt%, of triethyl phosphate.
- In those embodiments in which the first and/or second component consists of more than one substance, e.g., the first component consists essentially of DMPA, and the second component consists essentially of two or more of DMSO, triethyl phosphate, and one or more aprotic glycol ether, the amount of each substance in a particular component can vary widely and to convenience. The amount of each individual substance in the component can vary from 0 to 100 wt%, or from 1 to 99 wt%, or from 10 to 90 wt%, or from 20 to 80 wt% or from 30 to 70 wt%, or from 40 to 60 wt%, or 50 wt%, based on the weight of the component.
- Optional materials that are not essential to the operability of, but can be included in, the solvent systems of this invention include, but are not limited to, antioxidants, colorants, water scavengers, stabilizers, fillers, diluents (e.g., aromatic hydrocarbons), and the like. These materials do not have any material impact on the efficacy of the solvent system for providing a reaction medium for the synthesis of PI and/or PAA. These optional materials are used in known amounts, e.g., 0.10 to 5, or 4, or 3, or 2, or 1, weight percent based on the weight of the solvent system, and they are used in known ways.
- Solvent systems of this invention consisting of, or consisting essentially of, two or more compounds, e.g., DMPA and DMSO and/or triethyl phosphate and/or an aprotic glycol ether, are made using known equipment and known techniques. The individual components of the solvent system are commercially available, liquid at ambient conditions (23°C and atmospheric pressure), and can simply be mixed with one another using conventional mixing equipment and standard blending protocols. The components can be added to one another in any order including simultaneously.
- The solvent systems of this invention are eco-solvents, i.e., they do not have, or have at a reduced level, the toxicology issues associated with NMP. These solvent systems are used in the same manner as mediums for the synthesis of PAA and PI as NMP or other polar aprotic solvent.
- The following examples are nonlimiting illustrations of the invention.
-
- This scheme shows a simple reaction mechanism for producing a pyromellitic dianhydride (PMDA)/4,4'-diaminodiphenyl ether (ODA)-based PAA polymer with the exemplary repeating unit. There are many different types of dianhydride monomers and diamine monomers which can be polymerized through this illustrated polycondensation reaction to produce PAA and/or PI polymers with different properties and for different applications.
-
- Representative cyclic tetracarboxylic dianhydrides of formula I include, but are not limited to, 3,3'4,4'-biphenyltetracarboxylic dianhydride, 4,4'-(hexafluoroisopropylidene)-diphthalic anhydride, 3,3'4,4'-benzophenone-tetracarboxylic dianhydride, 1,2,3,4-cyclobutanetetra-carboxylic dianhydride, 3,3'4,4'-diphenyl-sulfonetetracarboxylic dianhydride, oxydiphthalic dianhydride, etc., such as those identified in
USP 9,346,927 - Other diamine monomers, beyond 4,4'-diaminodiphenyl ether, that can be used in the practice of this invention include, but are not limited to, those described by formula II in which R' is an unsubstituted or substituted aliphatic or aromatic group.
H2N-R'-NH2 (II)
- Preferably R' is an unsubstituted or substituted aromatic group. Representative diamines include, but are not limited to, 3,4'-diaminophenylether, 1,3-phenylenediamine, 1,4-phenylenediamine, 4,4'-diaminodiphenylsulfone, 2,4-diamino-toluene, 4,4'-diaminodiphenylmethane, 2,2-bis(4-aminophenyl)-1,1,1,3,3,3-hexafluoropropane, 1,4-bis(3-amino-phenoxy)benzene, 3,3'-dimethylbenzidine, etc., such as those identified in
USP 9,346,927 -
- In one embodiment the PAA polymer is thermally converted, e.g., heated, into the PI polymer. In one embodiment the PAA is chemically converted, e.g., the PAA polymer is reacted with a ring-closing/dehydrating imidization agent such as acetic anhydride with a base catalyst, into the PI polymer. In one embodiment the PAA polymer is converted into the PI polymer using a combination of thermal and chemical techniques, e.g., reacting the PAA polymer with an imidization reagent at an elevated temperature. Imidization reagents and synthesis conditions for PI polymers are well known in the art, and are described in, among other publications,
USP 3,410,826 ,5,789,524 and5,919,892 . - Inherent viscosity, ηinh, (also known as logarithmic viscosity number) is measured and calculated from the equation
- For bulk solution viscosity measurements, an aliquot of the prepared 13 wt% polyamic acid solution is used to immerse a Brookfield LV Spindle 63 on a Brookfield DV-III Ultra Rheometer (Brookfield Engineering Laboratories, Middleboro, Massachusetts, U.S.A.) with bulk solution viscosity measured in centipoise (cP) at 20°C and spindle speed of 10 rpm. Bulk solution viscosity measurements reflect the weight percent polyamic acid, polyamic acid molecular weight, and how the polymer interacts with the solvent. It is preferred that polyamic acid solution of equivalent weight percent solids and equivalent molecular weight in an alternative solvent to NMP have a bulk viscosity of no more than 3X of that measured in NMP, more preferably no more than 2X of that measured in NMP, even more preferably comparable or less than that measured in NMP.
- Into a magnetically stirred, 3-neck, 100 mLround-bottom flask under nitrogen sweep with Dean-Stark type trap and condenser is loaded 1-methyl-2-pyrrolidinone (50 mL) and toluene (10 mL). Toluene (10 mL) is distilled into Dean-Stark type trap and drained with Dean-Stark trap and condenser removed and flask placed under positive nitrogen. 4,4'-Diaminodiphenyl ether (3.676 g, 18.36 mmol) is added to the flask and dissolves at room temperature. Sublimed pyromellitic dianhydride (3.924 g, 17.99 mmol) and sublimed maleic anhydride (0.072 g, 0.73 mmol) are added to the flask with overhead stirring initiated. After 44 hours reaction time at room temperature, poly(amic acid) inherent viscosity = 1.04 dL/g (1-methyl-2-pyrrolidinone, 0.10 g/dL, 30.0°C) and bulk solution viscosity = 2699 centipoise (20°C, 10 rpm on Brookfield DV-III Ultra with LV Spindle 63).
- Into a magnetically stirred, 3-neck, 100 mL round-bottom flask under positive nitrogen is injected anhydrous dimethyl sulfoxide (46.7 mL). 4,4'-Diaminodiphenyl ether (3.676 g, 18.36 mmol) is added to the flask and dissolves at room temperature. Sublimed pyromellitic dianhydride (3.924 g, 17.99 mmol) and sublimed maleic anhydride (0.072 g, 0.73 mmol) are added to the flask with overhead stirring initiated. After 44 hours reaction time at room temperature, poly(amic acid) inherent viscosity = 1.12 dL/g (1-methyl-2-pyrrolidinone, 0.10 g/dL, 30.0°C) and bulk solution viscosity = 4043 centipoise (20°C, 10 rpm on Brookfield DV-III Ultra with LV Spindle 63).
- Into a magnetically stirred, 3-neck, 100 mLround-bottom flask under nitrogen sweep with Dean-Stark type trap and condenser is loaded triethyl phosphate (47.9 mL) and toluene (10 mL). Toluene (10 mL) is distilled into Dean-Stark type trap and drained with Dean-Stark trap and condenser removed and flask placed under positive nitrogen. 4,4'-Diaminodiphenyl ether (3.676 g, 18.36 mmol) is added to the flask and dissolves at room temperature. Sublimed pyromellitic dianhydride (3.924 g, 17.99 mmol) and sublimed maleic anhydride (0.072 g, 0.73 mmol) are added to the flask with overhead stirring initiated. After 44 hours reaction time at room temperature, poly(amic acid) inherent viscosity = 1.15 dL/g (1-methyl-2-pyrrolidinone, 0.10 g/dL, 30.0°C) and bulk solution viscosity = 5915 centipoise (20°C, 10 rpm on Brookfield DV-III Ultra with LV Spindle 63).
- Into a magnetically stirred, 3-neck, 100 mL round-bottom flask under nitrogen sweep with Dean-Stark type trap and condenser is loaded N,N-dimethylpropionamide (45 mL) and toluene (10 mL). Toluene (10 mL) is distilled into Dean-Stark type trap and drained with Dean-Stark trap and condenser removed and flask placed under positive nitrogen. 4,4'-Diaminodiphenyl ether (2.964 g, 14.80 mmol) is added to the flask and dissolves at room temperature. Sublimed pyromellitic dianhydride (3.164 g, 14.51 mmol) and sublimed maleic anhydride (0.058 g, 0.59 mmol) are added to the flask with overhead stirring initiated. After 44 hours reaction time at room temperature, poly(amic acid) inherent viscosity = 1.15 dL/g (1-methyl-2-pyrrolidinone, 0.10 g/dL, 30.0°C) and bulk solution viscosity = 1272 centipoise (20°C, 10 rpm on Brookfield DV-III Ultra with LV Spindle 63).
- Into a magnetically stirred, 3-neck, 100 mL round-bottom flask under nitrogen sweep with Dean-Stark type trap and condenser is loaded N,N-dimethylpropionamide (25 mL) and DOWANOL™ PMA/propylene glycol methyl ether acetate (35 mL). DOWANOL™ PMA (10 mL) is distilled into Dean-Stark type trap and drained with Dean-Stark trap and condenser removed and flask placed under positive nitrogen. 4,4'-Diaminodiphenyl ether (3.378 g, 16.87 mmol) is added to the flask and dissolves at room temperature. Sublimed pyromellitic dianhydride (3.606 g, 16.53 mmol) and sublimed maleic anhydride (0.066 g, 0.67 mmol) are added to the flask with overhead stirring initiated. After 44 hours reaction time at room temperature, poly(amic acid) inherent viscosity = 1.26 dL/g (1-methyl-2-pyrrolidinone, 0.10 g/dL, 30.0°C) and bulk solution viscosity = 4647 centipoise (20°C, 10 rpm on Brookfield DV-III Ultra with LV Spindle 63).
- Into a magnetically stirred, 3-neck, 100 mL round-bottom flask under nitrogen sweep with Dean-Stark type trap and condenser is loaded triethyl phosphate (25 mL), N,N-dimethylpropionamide (25 mL), and toluene (10 mL). Toluene (10 mL) is distilled into Dean-Stark type trap and drained with Dean-Stark trap and condenser removed and flask placed under positive nitrogen. 4,4'-Diaminodiphenyl ether (3.565 g, 17.80 mmol) is added to the flask and dissolves at room temperature. Sublimed pyromellitic dianhydride (3.806 g, 17.45 mmol) and sublimed maleic anhydride (0.070 g, 0.71 mmol) are added to the flask with overhead stirring initiated. After 44 hours reaction time at room temperature, poly(amic acid) inherent viscosity = 1.26 dL/g (1-methyl-2-pyrrolidinone, 0.10 g/dL, 30.0°C) and bulk solution viscosity = 2687 centipoise (20°C, 10 rpm on Brookfield DV-III Ultra with LV Spindle 63).
- Into a magnetically stirred, 3-neck, 100 mL round-bottom flask under nitrogen sweep with Dean-Stark type trap and condenser is loaded N,N-dimethylpropionamide (25 mL), and toluene (5 mL). Toluene (5 mL) is distilled into Dean-Stark type trap and drained with Dean-Stark trap and condenser removed and flask placed under positive nitrogen. Anhydrous dimethyl sulfoxide (25 mL) is injected into the flask. 4,4'-Diaminodiphenyl ether (3.616 g, 18.06 mmol) is added to the room temperature flask and dissolves at room temperature. Sublimed pyromellitic dianhydride (3.860 g, 17.70 mmol) and sublimed maleic anhydride (0.070g, 0.71 mmol) are added to the flask with overhead stirring initiated. After 44 hours reaction time at room temperature, poly(amic acid) inherent viscosity = 1.20 dL/g (1-methyl-2-pyrrolidinone, 0.10 /dL, 30.0°C) and bulk solution viscosity = 1560 centipoise (20°C, 10 rpm on Brookfield DV-III Ultra with LV Spindle 63).
- Into a magnetically stirred, 3-neck, 100 mL round-bottom flask under nitrogen sweep with Dean-Stark type trap and condenser is loaded butyl CELLOSOLVE™ acetate (17.5 mL), N,N-dimethylpropionamide (32.5 mL), and toluene (10 mL). Toluene (10 mL) is distilled into Dean-Stark type trap and drained with Dean-Stark trap and condenser removed and flask placed under positive nitrogen. 4,4'-Diaminodiphenyl ether (3.316 g, 16.56 mmol) is added to the room temperature flask and dissolves at room temperature. Sublimed pyromellitic dianhydride (3.540 g, 16.23 mmol) and sublimed maleic anhydride (0.065 g, 0.66 mmol) are added to the flask with overhead stirring initiated. After 44 hours reaction time at room temperature, polyamic acid inherent viscosity = 1.33 dL/g (1-methyl-2-pyrrolidinone, 0.10 g/dL, 30.0°C) and bulk solution viscosity = 3299 centipoise (20°C, 10 rpm on Brookfield DV-III Ultra with LV Spindle 63).
Table: Summary of Comparative Examples and Inventive Examples. Solvent η inh, dL/g (30°C, NMP, 0.1g/dL) Bulk viscosity @20°C, cPs CE1 NMP Controls 0.92 to 1.04 1824 to 2699 CE 2 Dimethyl sulfoxide (DMSO) 1.12 4043 CE 3 Triethyl phosphate (TEP) 1.15 5915 CE 4 N,N-dimethylpropionamide (DMPA) 1.15 1272 IE 1 50/50(v/v) DMPA/DOWANOL™ PMA 1.26 4847 IE 2 50/50 (v/v) DMPA/TEP 1.26 2687 IE 3 50/50 (v/v) DMPA/DMSO 1.20 1560 IE 4 65/35 (v/v) DMPA/Butyl CELLOSOLVE™ acetate 1.33 3299 - The inventive solvents of the Table illustrate that under the same reaction conditions of time, temperature, monomer ratio stoichiometries, and solids loadings as the NMP control polymerizations, that the inventive solvents result in equivalent or higher molecular weight (MW) and in some cases, in spite of the higher molecular weight, have a lower bulk solution viscosity value.
- DMPA shows the comparable or higher molecular weight of the synthesized PAA compared to NMP. However, the bulk viscosity of the PAA solution is much lower than NMP without adding any additives to control the bulk viscosity of the PAA solution. Lowering both the bulk viscosity and the surface tension provide an advantage for the downstream coating or filming process.
- Blends of DMPA with other polar aprotic solvents like TEP and DMSO show comparable or higher molecular weight of the synthesized PAA compared to NMP. The bulk viscosity of the blends are lower or comparable which will facilitate the downstream processing (as well as lower cost) providing flexibility in having lower bulk viscosities at equivalent molecular weight or allow higher polymer solution loadings than the comparative examples
- Blends of DMPA with aprotic solvents like DOWANOL™ PMA and Butyl CELLOSOLVE™ acetate also show the comparable or higher MW of the synthesized PAA compared to NMP. However, the bulk viscosity of the PAA solution is higher than the PAA prepared with NMP. The bulk viscosity can be controlled via molecular weight control during the reaction and/or adding viscosity thinner as additive to lower the bulk viscosity of the PAA solution. These mixed/blend solvent systems can provide advantages on the downstream processing such as easier casting/spin coating, easier evaporation, better color, better/faster processing to make coatings/films due to the attributes of the aprotic glycol ethers that relate to their properties/attributes whether it be viscosity, solubility parameters, volatility/evaporation rate, etc.
Claims (11)
- A process for synthesizing poly(amic acid) polymer, the process comprising the step of contacting under synthesis conditions and in a solvent system, (i) a cyclic tetracarboxylic dianhydride, and (ii) a diamine monomer, wherein the solvent system consists essentially of:(A) a first component consisting essentially of N,N-dimethyl propionamide (DMPA), and(B) a second component consisting essentially of at least one of a sulfoxide, an alkyl phosphate, and an aprotic glycol ether.
- A process for synthesizing a polyimide polymer from a poly(amic acid) polymer in a solvent system, wherein the solvent system consists essentially of:(A) a first component consisting of N,N-dimethyl propionamide (DMPA), and(B) a second component consisting essentially of at least one of a sulfoxide, an alkyl phosphate, and an aprotic glycol ether.
- The process of claim 1 or 2 in which the solvent system consists essentially of, based on the weight of the solvent system, from 20 to 80 wt% of the first component and from 80 to 20 wt% of the second component.
- The process of claim 3 in which the second component consists essentially of at least one of DMSO, triethyl phosphate, propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol diacetate, ethylene glycol n-butyl ether acetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol dimethyl ether.
- The process of any of the preceding claims in which the second component is present and consists essentially of DMSO.
- The process of any one of claims 1 to 4 in which the second component is present and consists essentially of triethyl phosphate.
- The process of any one of claims 1 to 4 in which the second component consists essentially of at least one of propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol diacetate, ethylene glycol n-butyl ether acetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol dimethyl ether.
- The process of claim 3 in which the solvent system consists essentially of DMPA and DMSO.
- The process of Claim 3 in which the solvent system consists essentially of DMPA and triethyl phosphate.
- The process of Claim 3 in which the solvent system consists essentially of DMPA and at least one of propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol diacetate, ethylene glycol n-butyl ether acetate, diethylene glycol n-butyl ether acetate, and dipropylene glycol dimethyl ether.
- The process of claim 3 in which the solvent system consists of DMPA and propylene glycol methyl ether acetate.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2016/100465 WO2018058343A1 (en) | 2016-09-28 | 2016-09-28 | Dmpa-based solvent systems for the synthesis of poly(amic acid) and polyimide polymers |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3523353A1 EP3523353A1 (en) | 2019-08-14 |
EP3523353A4 EP3523353A4 (en) | 2020-04-22 |
EP3523353B1 true EP3523353B1 (en) | 2023-04-19 |
Family
ID=61762438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16882805.1A Active EP3523353B1 (en) | 2016-09-28 | 2016-09-28 | Dmpa-based solvent systems for the synthesis of poly(amic acid) and polyimide polymers |
Country Status (7)
Country | Link |
---|---|
US (1) | US10487178B2 (en) |
EP (1) | EP3523353B1 (en) |
JP (1) | JP6940408B2 (en) |
KR (1) | KR102646207B1 (en) |
CN (1) | CN108243612A (en) |
TW (1) | TWI750202B (en) |
WO (1) | WO2018058343A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10982047B2 (en) * | 2016-09-28 | 2021-04-20 | Dow Global Technologies Llc | Solvent systems for synthesis of poly(amic acid) and polyimide polymers |
BR112019004949A2 (en) * | 2016-09-28 | 2019-06-25 | Dow Global Technologies Llc | solvents for use in the electronics industry |
KR102117151B1 (en) * | 2017-09-29 | 2020-05-29 | 주식회사 엘지화학 | Polyimide precursor solution and polyimide film prepared by using same |
CN110922753A (en) * | 2018-09-20 | 2020-03-27 | 住友化学株式会社 | Composition for forming optical film |
TW202241999A (en) * | 2021-02-05 | 2022-11-01 | 南韓商Sk新技術股份有限公司 | Polyimide film-forming composition, method of preparing the same, and use thereof |
KR20220166922A (en) * | 2021-06-11 | 2022-12-20 | 에스케이이노베이션 주식회사 | Composition for forming polyimide film for cover window, a process for preparing same and uses thereof |
EP4509547A1 (en) * | 2022-04-15 | 2025-02-19 | PI Advanced Materials Co., Ltd. | Polyimide precursor |
KR20230153923A (en) * | 2022-04-29 | 2023-11-07 | 피아이첨단소재 주식회사 | Polyimide precursor |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3410826A (en) | 1967-04-10 | 1968-11-12 | Du Pont | Process for preparing shaped articles from polyamide acids before converting to insoluble polyimides |
JPS63243321A (en) * | 1987-03-26 | 1988-10-11 | Teijin Ltd | Production of molded polyimide precursor product |
JPH01260015A (en) * | 1988-04-11 | 1989-10-17 | Teijin Ltd | Production of high-elastic modulus fiber |
US5919892A (en) | 1994-10-31 | 1999-07-06 | The Dow Chemical Company | Polyamic acids and methods to convert polyamic acids into polyimidebenzoxazole films |
US5955568A (en) * | 1996-04-22 | 1999-09-21 | Korea Research Institute Of Chemical Technology | Process for preparing polyamideimide resins by direct polymerization |
US5789524A (en) | 1997-04-15 | 1998-08-04 | Olin Microelectronic Chemicals, Inc. | Chemical imidization reagent for polyimide synthesis |
JP4844721B2 (en) * | 2006-03-22 | 2011-12-28 | Jsr株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
WO2009154208A1 (en) * | 2008-06-17 | 2009-12-23 | 日産化学工業株式会社 | Liquid-crystal alignment material, liquid-crystal display element employing same, and novel diamine |
CN101649055A (en) * | 2008-08-14 | 2010-02-17 | 比亚迪股份有限公司 | Polyamide acid solution, polyimide plate and method for preparing same |
ES2784739T3 (en) * | 2008-10-01 | 2020-09-30 | Nippon Aerosil Co Ltd | Hydrophobic Silica Fine Particles and Electrophotographic Toner Composition |
US9346927B2 (en) | 2009-10-09 | 2016-05-24 | Ube Industries, Ltd. | Colored polyimide molded article, and process for production thereof |
JP6047864B2 (en) * | 2011-07-21 | 2016-12-21 | 宇部興産株式会社 | Polyimide precursor varnish and method for producing polyimide varnish |
JP2012041473A (en) * | 2010-08-20 | 2012-03-01 | Kaneka Corp | Polyimide film and method of manufacturing the film |
US9447240B2 (en) * | 2011-04-28 | 2016-09-20 | Nissan Chemical Industries, Ltd. | Polyimide precursor modified with dicarboxylic acid anhydride, imidized polyimide and liquid crystal aligning agent using it |
JP5895732B2 (en) * | 2011-07-01 | 2016-03-30 | Jnc株式会社 | Thermosetting ink composition and use thereof |
BR112014017062A2 (en) | 2012-01-09 | 2018-05-22 | Du Pont | aqueous binder solutions |
JP6146135B2 (en) * | 2012-08-30 | 2017-06-14 | Jsr株式会社 | Liquid crystal aligning agent, liquid crystal aligning film, method for producing liquid crystal aligning film, and liquid crystal display element |
KR20190142451A (en) * | 2012-09-04 | 2019-12-26 | 닛산 가가쿠 가부시키가이샤 | Polyimide, and heat resistant material |
JP6247112B2 (en) * | 2014-02-20 | 2017-12-13 | 東京応化工業株式会社 | Manufacturing method of polyimide resin, manufacturing method of polyimide film, manufacturing method of polyamic acid solution, polyimide film, and polyamic acid solution |
US9815941B2 (en) | 2014-04-17 | 2017-11-14 | Cymer-Dayton, Llc | Low toxicity solvent system for polyamdieimide and polyamide amic acid resin manufacture |
CN106232589B (en) | 2014-04-23 | 2019-10-22 | 捷客斯能源株式会社 | Tetracarboxylic dianhydride, polyamic acid, polyimides and those manufacturing method and polyamic acid solution |
EP3153539B1 (en) * | 2014-06-04 | 2024-12-18 | Ube Corporation | Method for producing polyimide film |
US20160208097A1 (en) | 2015-01-15 | 2016-07-21 | Rohm And Haas Electronic Materials Llc | Polyimide compositions and methods |
US10590306B2 (en) * | 2015-10-23 | 2020-03-17 | Toray Industries, Inc. | Resin composition for display substrate, and heat-resistant resin film, organic EL display substrate, and method for manufacturing organic EL display using same |
KR102580455B1 (en) * | 2015-12-31 | 2023-09-20 | 주식회사 동진쎄미켐 | Polyimidepolymer composition, method for producing thereof and method for producing polyimide film using the same |
-
2016
- 2016-09-28 KR KR1020177019480A patent/KR102646207B1/en active Active
- 2016-09-28 US US15/544,404 patent/US10487178B2/en active Active
- 2016-09-28 CN CN201680005999.6A patent/CN108243612A/en active Pending
- 2016-09-28 EP EP16882805.1A patent/EP3523353B1/en active Active
- 2016-09-28 WO PCT/CN2016/100465 patent/WO2018058343A1/en active Application Filing
- 2016-09-28 JP JP2017537512A patent/JP6940408B2/en active Active
-
2017
- 2017-07-18 TW TW106124022A patent/TWI750202B/en active
Also Published As
Publication number | Publication date |
---|---|
KR102646207B1 (en) | 2024-03-11 |
EP3523353A1 (en) | 2019-08-14 |
JP2019530756A (en) | 2019-10-24 |
US10487178B2 (en) | 2019-11-26 |
CN108243612A (en) | 2018-07-03 |
WO2018058343A1 (en) | 2018-04-05 |
US20190202989A1 (en) | 2019-07-04 |
TWI750202B (en) | 2021-12-21 |
EP3523353A4 (en) | 2020-04-22 |
KR20190059819A (en) | 2019-05-31 |
JP6940408B2 (en) | 2021-09-29 |
TW201829542A (en) | 2018-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3523353B1 (en) | Dmpa-based solvent systems for the synthesis of poly(amic acid) and polyimide polymers | |
KR101948819B1 (en) | Polyimide precursor composition, preparation method thereof and polyimide substrate prepared from the composition | |
CN105315665B (en) | Polyimide precursor composition, method for preparing polyimide precursor, polyimide molded body and preparation method thereof | |
KR101540827B1 (en) | Method for producing polyamic acid solution and polyamic acid solution | |
US20020016438A1 (en) | Polyimide silicone resin, process for its production, and polyimide silicone resin composition | |
US20110193016A1 (en) | Polyimide precursor solution composition | |
US20160185964A1 (en) | Polyimide precursor composition, polyimide molded article, and method for preparing polyimide molded article | |
KR20140037836A (en) | Liquid crystal aligning agent and liquid crystal alignment film using same | |
EP3252092A1 (en) | Polyamide acid composition and polyimide composition | |
JP2015178541A (en) | Polyimide precursor composition, method for manufacturing polyimide molded body, and polyimide molded body | |
JP2016124956A (en) | Polyamideimide precursor composition, polyamideimide molded article, and method for preparing polyamideimide molded article | |
JP6427905B2 (en) | Polyimide precursor composition, method for producing polyimide molded body, and polyimide molded body | |
EP1842870A2 (en) | Polymide silicone resin and thermosetting composition comprising the same | |
US9505886B2 (en) | Polyimide precursor composition, method for preparing polyimide precursor, polyimide molded article, and method for preparing polyimide molded article | |
US10982047B2 (en) | Solvent systems for synthesis of poly(amic acid) and polyimide polymers | |
CN109337070B (en) | Resin composition | |
US20090088536A1 (en) | Heat-resistant resin paste and method for producing same | |
EP3431525A1 (en) | Method for controlling polyimide backbone structure and method for producing polyimide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20170714 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: DOW GLOBAL TECHNOLOGIES LLC |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20200325 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C08G 73/10 20060101AFI20200319BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20211206 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20221110 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602016078963 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1561163 Country of ref document: AT Kind code of ref document: T Effective date: 20230515 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230526 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20230419 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1561163 Country of ref document: AT Kind code of ref document: T Effective date: 20230419 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230821 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230719 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230819 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230720 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602016078963 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20240122 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230928 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20230928 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230928 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230928 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230928 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230928 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230928 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230930 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230930 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240806 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20240816 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230419 |